Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 2/20 | 0.49 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.40 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.40 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.40 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.40 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.40 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13109319 | 0.99 | AKR1C3 (0.50) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL11724960 | 0.91 | AKR1C3 (0.60) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL13483546 | 0.88 | AKR1C3 (0.49) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL13089879 | 0.87 | AKR1C3 (0.43) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL12913074 | 0.87 | AKR1C3 (0.43) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL13089790 | 0.85 | AKR1C3 (0.44) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL13730685 | 0.85 | PTGS2 (0.47) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL14605797 | 0.85 | PTGS2 (0.46) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL15834949 | 0.84 | AKR1C3 (0.43) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 | |
| SCHEMBL10729842 | 0.84 | PTGS2 (0.62) | AKR1C3AKR1C2PTGS2TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1526839-B1 | ORAL PHARMACEUTICAL FORMS OF LIQUID DRUGS HAVING IMPROVED BIOAVAILABILITY | NICOX SA (FR) | 2007-03-14 | — | — | EP | disclosed |